Premium

‘Dangerous.. may bypass regulatory checks’: DMK’s Kanimozhi Somu on quick commerce companies delivering medicines

DMK MP Kanimozhi NVN Somu raised concern over quick commerce companies delivering medicines, flagging that they might be violating drug regulations.

DMK MP Kanimozhi flagged concern over quick commerce firms delivering drugs. (PTI photo)DMK MP Kanimozhi flagged concern over quick commerce firms delivering drugs. (Photo: X)

Kanimozhi NVN Somu on Wednesday expressed concern over quick commerce companies delivering medicines saying they might be violating drug regulations, and asked the government to stop such deliveries immediately.

Raising the matter during the Zero Hour in the Rajya Sabha, she said the ultra-fast delivery model may increase the possibility of expired/counterfeit medicines reaching people.

The DMK MP also said the 10-minute delivery of medicines model violates Indian drug regulations and poses health and safety risks to the public.

Story continues below this ad

She further said a pan India organisation of chemists and druggists has also expressed serious concern over the model. “This is a dangerous model…(this will) bypass essential regulatory checks necessary for patients safety,” Kanimozhi said.

She said the distribution and supply of medicines in India involve strict protocols to prevent harm to consumers. The MP urged the government to take immediate action to stop the delivery of medicines by quick delivery companies.

In his Zero Hour mention, Naresh Bansal (BJP) demanded censorship on OTT platforms to protect social and cultural values.

Iranna Kadadi (BJP) demanded an increase in financial assistance from Rs 1.3 lakh to Rs 2 lakh given under the Pradhan Mantri Awas Yojna (Gramin).

Story continues below this ad

Sadanand Mhalu Shet Tanavde (BJP) spoke on the need to address the challenges faced by small and micro enterprises in Goa due to an “inefficient” banking system.

Stay updated with the latest - Click here to follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Loading Taboola...
Advertisement